Jen Moderator Session On Investment Cycles

VCs with €6Bn in Funds to Invest Visit Dublin

The sixth annual MedTech Strategist Innovation Summit Dublin will take place this April in the Shelbourne Hotel. Dozens of Venture Capital firms whose funds together amount to over €6 billion will attend the Summit, which is expected to attract some of the most promising medtech innovations from throughout Europe, the U.S. and Asia.

As platinum sponsors every year since the first medtech conference came to Dublin back in 2013, Seroba is delighted to be involved once again in bringing to Ireland what is now widely recognised as the top European medtech partnering event.
The 3-day forum will bring together more than 500 leading experts, innovators, and key decision-makers to discuss the critical challenges facing the ever-evolving global medtech community. The program will feature presentations by more than 45 innovative medtech start-ups from around the world. The start-ups will be seeking investment and partnerships and the opportunity to be present at the insightful corporate, venture capital and commercialisation panel discussions and special guest-speaker sessions.

Seroba’s partners will take part in several of the panel discussions on venture capital investment in Europe and, during the conference, they will meet with numerous start-up companies who are seeking funding to bring their medtech innovations to market.

Keynote presentations at the conference will be from: William Cohn MD, Vice President for John-son & Johnson Medical Devices Companies and the Executive Director of the new Center for De-vice Innovation at the Texas Medical Center in Houston, Texas; Martin Rothman MD, Venture Partner at Sofinnova Partners; Scott Huennekens, Former CEO of Verb Surgical; and Josh Ma-kower General Partner, NEA and Founder of ExploraMed.

Full event & registration details can be found here: www.medtechstrategist.com/dublin-2019

Ends.

About MedTech Strategist:
MedTech Strategist, a leading information and investment conferences provider focused exclusively on the rapidly evolving global medical device industry, is led by managing partners and co-editors-in-chief David Cassak and Stephen Levin, along with a seasoned editorial team and staff. With more than 100 years of combined experience, our team provides our community with both breadth and depth in the industry publication, MedTech Strategist, and access to unparalleled connections at our global investment and partnering conferences. In addition, the MedTech Strategist Community Blog complements the strategic medtech industry coverage that our publication is known for, with candid video interviews and short perspective articles focusing on the people and the passionate innovation behind the most exciting trends in the global device space. Think Strategically. Join Our Community. www.medtechstrategist.com

Sponsors:
Along with Seroba, other Platinum Sponsors for the Dublin 2019 event include Johnson & Johnson, Medtronic, Medmarc, EIT Health, Enterprise Ireland, Eugene F. Collins, EY, Lightstone Ventures, The Mullings Group, MVR Ltd., and NAMSA.

Gold Sponsors include AdvaMed, BTIG, CBSET, Covance, genae, Gilde Healthcare, ICON, IMMR, Locust Walk Partners, Olympus, Silicon Valley Bank, Strategic Healthcare Invest-ment Partners, Syneos Health, Syntactx, and Team-Consulting Medical Devices.

Supporting Partners for the event include The Irish Medtech Association/Ibec, Medgadget, MedTech Engine and MedTech Europe.

Update: If you didn’t make it to the 2019 Summit in Dublin, you can watch a few of the highlights below (1min 7secs). Save the date now to join us at next year’s conference – April 21-23 2020.

Recent Articles

Home V2

Seroba Invests in Storm Therapeutics

20 May 2019.  STORM Therapeutics (“STORM”), the drug discovery company tackling disease through modulating RNA modifying enzymes, has announced that […]

Read More
Quanta SC+

Quanta SC+ confirmed as safe and easy to use

Alcester, Warwickshire, UK, 15 April 2019.  Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a pioneering medical […]

Read More
Fusion

Fusion Raises $105m in Series B Financing

April 2nd 2019. Hamilton, Canada and Dublin, Ireland.  Seroba’s portfolio company, Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle […]

Read More
Fusion News

First Patient Dosed in Fusion Phase I trial

Boston, Massachusetts & Hamilton, Ontario. February 19, 2019.  Seroba portfolio company, Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics (targeted […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top